Literature DB >> 20013810

Nerve invasion distance is dependent on laminin gamma2 in tumors of pancreatic cancer.

Shuichi Mitsunaga1, Satoshi Fujii, Genichiro Ishii, Taira Kinoshita, Takahiro Hasebe, Kazuhiko Aoyagi, Hiroki Sasaki, Atsushi Ochiai.   

Abstract

The distance of nerve invasion is an important prognostic factor in pancreatic cancer. The extracellular matrix (ECM) of nerve, mainly composed of laminin, collagen IV and anchoring fibrils, might affect nerve invasion. However, this relationship has not been demonstrated. Our study aimed at discovering the promoting factor of nerve invasion within the tumoral ECM. An animal model was established to evaluate the distance of nerve invasion in murine sciatic nerves by intraneural injection of 6 human pancreatic cancer cell lines. mRNA expression of laminins and anchoring fibrils was compared to the distance of nerve invasion for each cancer cell line. A target molecule provided the strong association between mRNA expression and the distance of nerve invasion. To evaluate the role of a target molecule in nerve invasion, protein expression and function were examined using an animal model and surgical cases. Cancer cells with high laminin gamma2 mRNA and protein expression in their basement membranes were associated with long nerve invasion. Knockdown of laminin gamma2 in cancer cells significantly shortened nerve invasion in the animal model. In 75 patients with pancreatic cancer, a large distance of nerve invasion was associated with high expression levels of laminin gamma2 mRNA and basement membranous deposition of laminin gamma2 protein. Our results indicate that laminin gamma2 plays an important role in nerve invasion. The measurement of the nerve invasion distance in our mouse nerve invasion model is useful for evaluating the molecular mechanisms of nerve invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20013810     DOI: 10.1002/ijc.25104

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.

Authors:  Alison Chan; Ioannis Prassas; Apostolos Dimitromanolakis; Randall E Brand; Stefano Serra; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  Clin Cancer Res       Date:  2014-09-19       Impact factor: 12.531

3.  Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues.

Authors:  Hari Kosanam; Ioannis Prassas; Caitlin C Chrystoja; Ireena Soleas; Alison Chan; Apostolos Dimitromanolakis; Ivan M Blasutig; Felix Rückert; Robert Gruetzmann; Christian Pilarsky; Masato Maekawa; Randall Brand; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2013-06-24       Impact factor: 5.911

4.  Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.

Authors:  Fang Liu; Murray Korc
Journal:  Mol Cancer Ther       Date:  2012-08-06       Impact factor: 6.261

5.  Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

Authors:  Jian Zheng; Jonathan M Hernandez; Alexandre Doussot; Linda Bojmar; Constantinos P Zambirinis; Bruno Costa-Silva; Elke J A H van Beek; Milica T Mark; Henrik Molina; Gokce Askan; Olca Basturk; Mithat Gonen; T Peter Kingham; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; David Lyden; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2018-01-12       Impact factor: 3.647

6.  LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.

Authors:  Yasuyuki Okada; Naoki Takahashi; Tetsuji Takayama; Ajay Goel
Journal:  Carcinogenesis       Date:  2021-04-30       Impact factor: 4.944

7.  Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path method.

Authors:  Shuhua Shen; Tuantuan Gui; Chengcheng Ma
Journal:  Oncotarget       Date:  2017-06-20

8.  Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma.

Authors:  Chengkun Yang; Zhengqian Liu; Xianmin Zeng; Qiongyuan Wu; Xiwen Liao; Xiangkun Wang; Chuangye Han; Tingdong Yu; Guangzhi Zhu; Wei Qin; Tao Peng
Journal:  Aging (Albany NY)       Date:  2019-06-10       Impact factor: 5.682

9.  MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells.

Authors:  Chumei Huang; Yaqing Li; Yubo Guo; Zuoquan Zhang; Guoda Lian; Yinting Chen; Jian Li; Yonghui Su; Jiajia Li; Kege Yang; Shaojie Chen; Hong Su; Kaihong Huang; Linjuan Zeng
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

Review 10.  Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

Authors:  Robert S O'Neill; Alina Stoita
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.